Related Experiment Video

Updated: Jun 23, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy

David Pace1

  • 1Department of Paediatrics, Mater Dei Hospital, Tal-Qroqq, Msida, Malta. dpace@mail.global.net.mt

Expert Review of Vaccines
|April 29, 2009
PubMed

Insights

A new quadrivalent meningococcal vaccine (MenACYW-CRM197) shows promise for protecting infants and adolescents against invasive meningococcal disease caused by serogroups A, C, Y, and W-135.

Area of Science:

  • * Immunology
  • * Vaccinology
  • * Public Health

Background:

  • * Invasive meningococcal disease (IMD) poses a significant global health challenge, disproportionately affecting infants and adolescents.
  • * Serogroup C meningococcal vaccines have successfully reduced disease burden, but broader protection is needed.
  • * Existing quadrivalent vaccines protect individuals aged 2-55, leaving younger populations vulnerable.

Purpose of the Study:

  • * To discuss a novel investigational quadrivalent meningococcal glycoconjugate vaccine (MenACYW-CRM197).
  • * To evaluate its potential for controlling invasive disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.
  • * To highlight its immunogenicity in infants, extending protection to a vulnerable age group.

Main Methods:

  • * Review of existing literature on meningococcal vaccines.
  • * Discussion of the MenACYW-CRM197 vaccine formulation and its properties.
  • * Analysis of its potential clinical application and public health impact.

Main Results:

  • * The MenACYW-CRM197 vaccine is immunogenic from infancy.
  • * It offers potential for broad protection against four key meningococcal serogroups (A, C, Y, W-135).
  • * This novel formulation may extend protection to the youngest and most susceptible populations.

Conclusions:

  • * The MenACYW-CRM197 vaccine represents a significant advancement in meningococcal disease prevention.
  • * Its infant immunogenicity holds the potential to significantly reduce the burden of invasive meningococcal disease in this age group.
  • * This vaccine could play a crucial role in controlling IMD caused by serogroups A, C, Y, and W-135 globally.

More Related Videos

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...